» Articles » PMID: 32086938

The SARS, MERS and Novel Coronavirus (COVID-19) Epidemics, the Newest and Biggest Global Health Threats: What Lessons Have We Learned?

Overview
Journal Int J Epidemiol
Specialty Public Health
Date 2020 Feb 23
PMID 32086938
Citations 628
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To provide an overview of the three major deadly coronaviruses and identify areas for improvement of future preparedness plans, as well as provide a critical assessment of the risk factors and actionable items for stopping their spread, utilizing lessons learned from the first two deadly coronavirus outbreaks, as well as initial reports from the current novel coronavirus (COVID-19) epidemic in Wuhan, China.

Methods: Utilizing the Centers for Disease Control and Prevention (CDC, USA) website, and a comprehensive review of PubMed literature, we obtained information regarding clinical signs and symptoms, treatment and diagnosis, transmission methods, protection methods and risk factors for Middle East respiratory syndrome (MERS), severe acute respiratory syndrome (SARS) and COVID-19. Comparisons between the viruses were made.

Results: Inadequate risk assessment regarding the urgency of the situation, and limited reporting on the virus within China has, in part, led to the rapid spread of COVID-19 throughout mainland China and into proximal and distant countries. Compared with SARS and MERS, COVID-19 has spread more rapidly, due in part to increased globalization and the focus of the epidemic. Wuhan, China is a large hub connecting the North, South, East and West of China via railways and a major international airport. The availability of connecting flights, the timing of the outbreak during the Chinese (Lunar) New Year, and the massive rail transit hub located in Wuhan has enabled the virus to perforate throughout China, and eventually, globally.

Conclusions: We conclude that we did not learn from the two prior epidemics of coronavirus and were ill-prepared to deal with the challenges the COVID-19 epidemic has posed. Future research should attempt to address the uses and implications of internet of things (IoT) technologies for mapping the spread of infection.

Citing Articles

Investigating the association between major dietary patterns and disease outcomes in diabetic and non-diabetic patients with COVID-19: a cross-sectional study.

Amrollahi A, Hariri Z, Sabaghian T, Kalbasi S, Nikpayam O, Sohrab G J Diabetes Metab Disord. 2025; 24(1):74.

PMID: 40041674 PMC: 11872832. DOI: 10.1007/s40200-025-01587-8.


Social goals under a neoliberal agenda: measures to promote equality in European higher education read through a Foucauldian lens.

Baciu E, Lazar T, Totan R Front Sociol. 2025; 10:1492863.

PMID: 39995888 PMC: 11847839. DOI: 10.3389/fsoc.2025.1492863.


Strategies to Ensure Effective and Safe Patient Care in Intensive Care Units During Biological Events: A Delphi Study.

Rad M, Fallahi-Khshknab M, Mohammadi Shahboulaghi F, Nourozi K, Khankeh H J Caring Sci. 2025; 13(4):267-275.

PMID: 39974829 PMC: 11833441. DOI: 10.34172/jcs.33372.


Neck pain and distance learning: A pain in the neck for university students during COVID-19.

Musaad Mohamed A, Abdulkafi Abbara M, Alaaeldin Bashier S, Aasim Elkhidir D, Hussein A, Ranade A F1000Res. 2025; 13:307.

PMID: 39931325 PMC: 11809631. DOI: 10.12688/f1000research.145874.1.


Predicting Factors Affecting the Behavior of Healthcare Employees in the Use of Personal Protective Equipment During Epidemics Based on Godin et al's Model: A Study in Iran.

Marzaleh M, Bastani P, Raeyat Mohtashami A, Farhadi P, Ghanbari S, Ravangard R Health Serv Insights. 2025; 18:11786329251316668.

PMID: 39917359 PMC: 11800262. DOI: 10.1177/11786329251316668.


References
1.
Chan-Yeung M, Xu R . SARS: epidemiology. Respirology. 2004; 8 Suppl:S9-14. PMC: 7169193. DOI: 10.1046/j.1440-1843.2003.00518.x. View

2.
Leung G, Hedley A, Ho L, Chau P, Wong I, Thach T . The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med. 2004; 141(9):662-73. DOI: 10.7326/0003-4819-141-9-200411020-00006. View

3.
Sheahan T, Sims A, Graham R, Menachery V, Gralinski L, Case J . Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med. 2017; 9(396). PMC: 5567817. DOI: 10.1126/scitranslmed.aal3653. View

4.
Chu C, Cheng V, Hung I, Wong M, Chan K, Chan K . Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004; 59(3):252-6. PMC: 1746980. DOI: 10.1136/thorax.2003.012658. View

5.
Assiri A, Al-Tawfiq J, Al-Rabeeah A, Al-Rabiah F, Al-Hajjar S, Al-Barrak A . Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013; 13(9):752-61. PMC: 7185445. DOI: 10.1016/S1473-3099(13)70204-4. View